Trials / Terminated
TerminatedNCT00588250
Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates
Prospective Randomized Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Hypothesis: a special solution for improving human embryo implantation, when added to the solution during embryo transfer, will improve implantation rates in embryo transfers using previously frozen embryos.
Detailed description
EmbryoGlue (TM) is added to embryo transfer solutions immediately prior to the transfer of frozen-thawed human embryos before placement of embryos into the patient uterus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | EmbryoGlue | G2 culture media from Vitrolife which contains hyaluronic acid |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2005-06-01
- Completion
- 2005-06-01
- First posted
- 2008-01-08
- Last updated
- 2023-05-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00588250. Inclusion in this directory is not an endorsement.